The relationship between blood mercury level and osteoporosis in postmenopausal women

Menopause

Volumn 19, Issue 5, 2012, Pages 575-581

  Cho, Geum Joon ^a   Park, Hyun Tae ^a   Shin, Jung Ho ^a   Hur, Jun Young ^a   Kim, Sun Haeng ^a   Lee, Kyu Wan ^a   Kim, Tak ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Arsenic; Cadmium; Lead; Mercury; Osteoporosis

Indexed keywords

ALCOHOL; ARSENIC; CADMIUM; CALCIUM; LEAD; MERCURY; ORAL CONTRACEPTIVE AGENT; VITAMIN D;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARSENIC BLOOD LEVEL; ARTICLE; BODY MASS; BONE DENSITY; CADMIUM BLOOD LEVEL; CALCIUM INTAKE; CALORIC INTAKE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EXERCISE; FEMALE; FISH MEAT; FOOD INTAKE; HORMONAL THERAPY; HUMAN; KOREA; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; MERCURY BLOOD LEVEL; ORAL CONTRACEPTION; POSTMENOPAUSE OSTEOPOROSIS; SMOKING; TRACE METAL BLOOD LEVEL; VITAMIN BLOOD LEVEL; AGED; BLOOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PREVALENCE; SOUTH KOREA; STATISTICAL MODEL;

AGED; ARSENIC; BONE DENSITY; CADMIUM; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LEAD; LOGISTIC MODELS; MERCURY; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PREVALENCE; REPUBLIC OF KOREA;

EID: 84860775574     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e3182377294     Document Type: Article

References (47)

1. Dowd TL, Rosen JF. Gupta RK. 31P NMR and saturation transfer studies of the effect of Pb2+ on cultured osteoblastic bone cells. J Biol Chem 1990;265:20833-20838.
2. Long GJ, Rosen JF, Pounds JG. Cellular lead toxicity and metabolism in primary and clonal osteoblastic bone cells. Toxicol Appl Pharmacol 1990;102:346-361.
3. Pounds JG, Long GJ, Rosen JF. Cellular and molecular toxicity of lead in bone. Environ Health Perspect 1991;91:17-32.
4. Suzuki N, Yamamoto M, Watanabe K, Kambegawa A, Hattori A. Both mercury and cadmium directly influence calcium homeostasis resulting from the suppression of scale bone cells: the scale is a good model for the evaluation of heavy metals in bone metabolism. J Bone Miner Metab 2004;22:439-446.
5. Tang CH, Chiu YC, Huang CF, Chen YW, Chen PC. Arsenic induces cell apoptosis in cultured osteoblasts through endoplasmic reticulum stress. Toxicol Appl Pharmacol 2009;241:173-181.
6. Akesson A, Bjellerup P, Lundh T, et al. Cadmium-induced effects on bone in a population-based study of women. Environ Health Perspect 2006;114:830-834.
7. Escribano A, Revilla M, Hernandez ER, et al. Effect of lead on bone development and bone mass: a morphometric, densitometric, and histomorphometric study in growing rats. Calcif Tissue Int 1997;60:200-203.
8. Gruber HE, Gonick HC, Khalil-Manesh F, et al. Osteopenia induced by long-term, low-and high-level exposure of the adult rat to lead. Miner Electrolyte Metab 1997;23:65-73.
9. Horiguchi H, Oguma E, Sasaki S, et al. Environmental exposure to cadmium at a level insufficient to induce renal tubular dysfunction does not affect bone density among female Japanese farmers. Environ Res 2005; 97:83-92.
10. Jarup L, Akesson A. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 2009;238:201-208.
11. Schutte R, Nawrot TS, Richart T, et al. Bone resorption and environmental exposure to cadmium in women: a population study. Environ Health Perspect 2008;116:777-783.
12. Shin M, Paek D, Yoon C. The relationship between the bone mineral density and urinary cadmium concentration of residents in an industrial complex. Environ Res 2011;111:101-109.
13. Wu Q, Magnus JH, Hentz JG. Urinary cadmium, osteopenia, and osteoporosis in the US population. Osteoporos Int 2010;21:1449-1454.
14. Vahter M, Akesson A, Liden C, Ceccatelli S, Berglund M. Gender differences in the disposition and toxicity of metals. Environ Res 2007; 104:85-95.
15. Roberts JS, Silbergeld EK. Pregnancy, lactation, and menopause: how physiology and gender affect the toxicity of chemicals. Mt Sinai J Med 1995;62:343-355.
16. Silbergeld EK, Flaws JA. Chemicals and menopause: effects on age at menopause and on health status in the postmenopausal period. J Womens Health 1999;8:227-234.
17. Vahter M, Berglund M, Akesson A, Liden C. Metals and women's health. Environ Res 2002;88:145-155.
18. Staessen JA, Roels HA, Emelianov D, et al. Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Public Health and Environmental Exposure to Cadmium (PheeCad) Study Group. Lancet 1999;353:1140-1144.
19. Wang H, Zhu G, Shi Y, et al. Influence of environmental cadmium exposure on forearm bone density. J Bone Miner Res 2003;18:553-560.
20. Waugh EJ, Lam MA, Hawker GA, et al. Risk factors for low bone mass in healthy 40-60 year old women: a systematic review of the literature. Osteoporos Int 2009;20:1-21.
21. Kim NS, Lee BK. Blood total mercury and fish consumption in the Korean general population in KNHANES III, 2005. Sci Total Environ 2010;408:4841-4847.
22. Orimo H, Hayashi Y, Fukunaga M, et al. Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 2001;19:331-337.
23. Davis BJ, Price HC, O'Connor RW, Fernando R, Rowland AS, Morgan DL. Mercury vapor and female reproductive toxicity. Toxicol Sci 2001; 59:291-296.
24. Okazaki R, Inoue D, Shibata M, et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) or A. Endocrinology 2002;143:2349-2356.
25. Jo EM, Kim BG, Kim YM, et al. Blood mercury concentration and related factors in an urban coastal area in Korea. J Prev Med Public Health 2010;43:377-386.
26. Farina EK, Kiel DP, Roubenoff R, Schaefer EJ, Cupples LA, Tucker KL. Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr 2011;93: 1142-1151.
27. Koshihara Y, Takamori R, Nomura K, Sugiura S, Kurozumi S. Enhancement of in vitro mineralization in human osteoblasts by a novel prostaglandin A1 derivative TEI-3313. J Pharmacol Exp Ther 1991;258: 1120-1126.
28. Tasaki Y, Takamori R, Koshihara Y. Prostaglandin D2 metabolite stimulates collagen synthesis by human osteoblasts during calcification. Prostaglandins 1991;41:303-313.
29. Kim J, Jo I. Grains, vegetables, and fish dietary pattern is inversely associated with the risk of metabolic syndrome in South Korean adults. J Am Diet Assoc 2011;111:1141-1149.
30. Schulz C, Conrad A, Becker CK, Kolossa-Gehring M, Seiwert M, Seifert B. Twenty years of the German Environmental Survey (GerES): human biomonitoringVtemporal and spatial (West Germany/East Germany) differences in population exposure. Int J Hyg Environ Health 2007;210: 271-297.
31. Caldwell KL, Mortensen ME, Jones RL, Caudill SP, Osterloh JD. Total blood mercury concentrations in the U.S. population: 1999-2006. Int J Hyg Environ Health 2009;212:588-598.
32. Rice DC, Schoeny R, Mahaffey K. Methods and rationale for derivation of a reference dose for methylmercury by the U.S. EPA. Risk Anal 2003; 23:107-115.
33. Wallin E, Rylander L, Jonssson BA, Lundh T, Isaksson A, Hagmar L. Exposure to CB-153 and p,p¶-DDE and bone mineral density and bone metabolism markers in middle-aged and elderly men and women. Osteoporos Int 2005;16:2085-2094.
34. Agency for Toxic Substances and Disease Registry. Toxicological profile for cadmium. Available at: http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id= 48&tid=15. Accessed January 5, 2008.
35. Gallagher CM, Kovach JS, Meliker JR. Urinary cadmium and osteoporosis in U.S. Women 9 or = 50 years of age: NHANES 1988-1994 and 1999-2004. Environ Health Perspect 2008;116:1338-1343.
36. Shimbo S, Zhang ZW, Moon CS, et al. Correlation between urine and blood concentrations, and dietary intake of cadmium and lead among women in the general population of Japan. Int Arch Occup Environ Health 2000;73:163-170.
37. Wittmers LE Jr, Aufderheide AC, Wallgren J, Rapp G Jr, Alich A. Lead in bone. IV. Distribution of lead in the human skeleton. Arch Environ Health 1988;43:381-391.
38. Silbergeld EK, Schwartz J, Mahaffey K. Lead and osteoporosis: mobilization of lead from bone in postmenopausal women. Environ Res 1988;47:79-94.
39. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000;21:115-137.
40. Menke A, Muntner P, Batuman V, et al. Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation 2006;114: 1388-1394.
41. Yamauchi H, Aminaka Y, Yoshida K, Sun G, Pi J, Waalkes MP. Evaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine. Toxicol Appl Pharmacol 2004;198:291-296.
42. Coronado-González JA, Del Razo LM, Garcia-Vargas G, Sanmiguel-Salazar F, Escobedode la Peña J. Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico. Environ Res 2007;104:383-389.
43. Agency for Toxic Substances and Disease Registry. Toxicological profile for Lead. Available at: http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id= 96&tid=22. Accessed August 5, 2011.
44. Gerhardsson L, Attewell R, Chettle DR, et al. In vivo measurements of lead in bone in long-term exposed lead smelter workers. Arch Environ Health 1993;48:147-156.
45. Agency for Toxic Substances and Disease Registry. Toxicological profile for Mercury. Available at: http://www.atsdr.cdc.gov/toxprofiles/tp.asp? id=115&tid=24. Accessed August 5, 2011.
46. Jonsson F, Sandborgh-Englund G, Johanson G. A compartmental model for the kinetics of mercury vapor in humans. Toxicol Appl Pharmacol 1999; 155:161-168.
47. Agency for Toxic Substances and Disease Registry. Toxicological profile for Arsenic. Available at: http://www.atsdr.cdc.gov/toxprofiles/tp.asp? id=22&tid=3. Accessed August 5, 2011.